Role of antibiotics and fungal microbiota in driving pulmonary allergic responses

Infection and Immunity

Volumn 72, Issue 9, 2004, Pages 4996-5003

  Noverr, Mairi C ^a   Noggle, Rachael M ^a   Toews, Galen B ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOPERAZONE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5;

AIRWAY; ALLERGIC ASTHMA; ALLERGY; ANIMAL CELL; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BACTERIAL OVERGROWTH; CANDIDA; CANDIDA ALBICANS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; IMMUNE RESPONSE; INTESTINE FLORA; LEUKOCYTE CULTURE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CEFOPERAZONE; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LUNG; MICE; MICE, INBRED C57BL; RESPIRATORY HYPERSENSITIVITY; SPORES, FUNGAL;

EID: 4544256857     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.9.4996-5003.2004     Document Type: Article

References (71)

1. Alm, J. S., J. Swartz, G. Lilja, A. Scheynius, and G. Pershagen. 1999. Atopy in children of families with an anthroposophic lifestyle. Lancet 353:1485-1488.
2. Angeli, V., C. Faveeuw, O. Roye, J. Fontaine, E. Teissier, A. Capron, I. Wolowczuk, M. Capron, and F. Trottein. 2001. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193:1135-1147.
3. Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
4. Bjorksten, B., E. Sepp, K. Julge, T. Voor, and M. Mikelsaar. 2001. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108:516-520.
5. Blease, K., C. Jakubzick, J. Westwick, N. Lukacs, S. L. Kunkel, and C. M. Hogaboam. 2001. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J. Immunol. 166:5219-5224.
6. Bottcher, M. F., E. K. Nordin, A. Sandin, T. Midtvedt, and B. Bjorksten. 2000. Microflora-associated characteristics in faeces from allergic and non-allergic infants. Clin. Exp. Allergy 30:1590-1596.
7. 2001. Calderone, R. A. (ed.) 2001. Candida and candidiasis. ASM Press, Washington, D.C.
8. Chung, Y., J. Cho, Y. S. Chang, S. H. Cho, and C. Y. Kang. 2002. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 206:408-423.
9. Constant, S. L., K. S. Lee, and K. Bottomly. 2000. Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur. J. Immunol. 30:84-47.
10. Cooper, M. D., P. W. Kincade, D. E. Bockman, and A. R. Lawton. 1974. Origin, distribution and differentiation of IgA-producing cells. Adv. Exp. Med. Biol. 45:13-22.
11. Demeure, C. E., L.-P. Yang, C. Desjardins, P. Raynauld, and G. Delespesse. 1997. Prostaglandin E2 primes naive T cells for the production of antiinflammatory cytokines. Eur. J. Immunol. 27:3526-3531.
12. Droste, J. H., M. H. Wieringa, J. J. Weyler, V. J. Nelen, P. A. Vermeire, and H. P. Van Bever. 2000. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin. Exp. Allergy 30:1547-1553.
13. Eyles, J. E., I. D. Spiers, E. D. Williamson, and H. O. Alpar. 2001. Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. J. Pharm. Pharmacol. 53:601-607.
14. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
15. Fogelmark, B., J. Thorn, and R. Rylander. 2001. Inhalation of (1→3)-beta-D-glucan causes airway eosinophilia. Mediat. Inflamm. 10:13-19.
16. Grunig, G., D. B. Corry, M. W. Leach, B. W. Seymour, V. P. Kurup, and D. M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185:1089-1099.
17. Grunig, G., and V. P. Kurup. 2003. Animal models of allergic bronchopulmonary aspergillosis. Front. Biosci. 8:e157-e171.
18. Hall, G., C. G. Houghton, J. U. Rahbek, J. R. Lamb, and E. R. Jarman. 2003. Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. Vaccine 21:549-561.
19. Hansen, G., G. Berry, R. H. DeKruyff, and D. T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Investig. 103:175-183.
20. Herve, M., V. Angeli, E. Pinzar, R. Wintjens, C. Faveeuw, S. Narumiya, A. Capron, Y. Urade, M. Capron, G. Riveau, and F. Trottein. 2003. Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol. 33:2764-2772.
21. Hogaboam, C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, and N. W. Lukacs. 2000. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 156:723-732.
22. International Study of Asthma and Allergies in Childhood Steering Committee. 1998. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225-1232.
23. Kalliomaki, M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:129-134.
24. Kalliomaki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076-1079.
25. Kankaanpaa, P., K. Nurmela, A. Erkkila, M. Kalliomaki, D. Holmberg-Marttila, S. Salminen, and E. Isolauri. 2001. Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy 56:633-638.
26. Kauffman, H. F. 2003. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front. Biosci. 8:e190-e196.
27. Kennedy, M. J., and P. A. Volz. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by C. albicans. Sabouraudia 23:265-273.
28. Kheradmand, F., A. Kiss, J. Xu, S. H. Lee, P. E. Kolattukudy, and D. B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:5904-5911.
29. Kirjavainen, P. V., T. Arvola, S. J. Salminen, and E. Isolauri. 2002. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51-55.
30. Kurup, V., H. Shen, and B. Banerjee. 2000. Respiratory fungal allergy. Microbes Infect. 2:1101-1110.
31. Kurup, V. P., H. Choi, A. Resniek, J. Kalbfleisch, and J. N. Fink. 1990. Immunopathological response of C57BL/6 and C3H/HeN mice to Aspergillus fumigatus antigens. Int. Arch. Allergy Appl. Immunol. 91:145-154.
32. Kurup, V. P., S. Mauze, H. Choi, B. W. Seymour, and R. L. Coffman. 1992. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 148:3783-3788.
33. Kurup, V. P., J. Q. Xia, R. Crameri, D. A. Rickaby, H. Y. Choi, S. Fluckiger, K. Blaser, C. A. Dawson, and K. J. Kelly. 2001. Purified recombinant A. fumigatus allergens induce different responses in mice. Clin. Immunol. 98: 327-336.
34. Larson, S. E., G. J. DaMert, C. Collins-Lech, and P. G. Sohnle. 1980. Direct stimulation of lymphokine production by cephalothin. J Infect. Dis. 142:265-272.
35. Maeda, Y., S. Noda, K. Tanaka, S. Sawamura, Y. Aiba, H. Ishikawa, H. Hasegawa, N. Kawabe, M. Miyasaka, and Y. Koga. 2001. The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology 204:442457.
36. Mannino, D. M., D. M. Homa, C. A. Pertowski, A. Ashizawa, L. L. Nixon, C. A. Johnson, L. B. Ball, E. Jack, and D. S. Kang. 1998. Surveillance for asthma-United States, 1960-1995. Morb. Mortal. Wkly. Rep. CDC Surveill. Summ. 47:1-27.
37. Matsuoka, T., M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, K. Kabashima, Y. Sugimoto, T. Kobayashi, F. Ushikubi, Y. Aze, N. Eguchi, Y. Urade, N. Yoshida, K. Kimura, A. Mizoguchi, Y. Honda, H. Nagai, and S. Narumiya. 2000. Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013-2017.
38. McGuirk, P., and K. H. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23:450-455.
39. McKeever, T. M., S. A. Lewis, C. Smith, J. Collins, H. Heatlie, M. Frischer, and R. Hubbard. 2002. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J. Allergy Clin. Immunol. 109:43-50.
40. Moreau, M. C., M. Coste, V. Gaboriau, and C. Dubuquoy. 1995. Oral tolerance to ovalbumin in mice: effect of some parameters on the induction and persistence of the suppression of systemic IgE and IgG antibody responses. Adv. Exp. Med. Biol. 371B:1229-1234.
41. Noverr, M. C., J. R. Erb-Downward, and G. B. Huffnagle. 2003. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16:517-533.
42. Noverr, M. C., S. M. Phare, G. B. Toews, M. J. Coffey, and G. B. Huffnagle. 2001. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 69:2957-2963.
43. Noverr, M. C., D. D. Williams, G. B. Toews, and G. B. Huffnagle. 2002. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70:400-402.
44. Peters-Golden, M. 2002. 'Good' lipids for asthma. Nat. Med. 8:931-932.
45. Peters-Golden, M. 2002. Open mind, open airways: broadening the paradigm of prostaglandins and allergic airway inflammation. Am. J. Respir. Crit. Care Med. 165:1035-1036.
46. Pickett, T. E., M. F. Pasetti, J. E. Galen, M. B. Sztein, and M. M. Levine. 2000. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 68:205-213.
47. Rosenfeldt, V., E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. H. Valerius, and A. Paerregaard. 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111:389-395.
48. Rouveix, B., F. Groult, and M. Levacher. 1987. Beta-lactam antibiotics and human lymphocyte function: the in vitro effect on blastogenesis, lymphokine production and suppressor cell functions. Int. J. Immunopharmacol. 9:567-575.
49. Russo, M., S. Jancar, A. L. Pereira de Siqueira, J. Mengel, E. Gomes, S. M. Ficker, and A. M. Caetano de Faria. 1998. Prevention of lung eosinophilic inflammation by oral tolerance. Immunol. Lett. 61:15-23.
50. Russo, M., M. A. Nahori, J. Lefort, E. Gomes, A. de Castro Keller, D. Rodriguez, O. G. Ribeiro, S. Adriouch, V. Gallois, A. M. de Faria, and B. B. Vargaftig. 2001. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Respir. Cell Mol. Biol. 24:518-526.
51. Scheffer, J., and W. Konig. 1993. Cephalosporins and inflammatory host reactions. Respiration 60(Suppl. 1):25-31.
52. Schuh, J. M., K. Blease, and C. M. Hogaboam. 2002. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J. Immunol. 168:1447-1456.
53. Schuh, J. M., C. A. Power, A. E. Proudfoot, S. L. Kunkel, N. W. Lukacs, and C. M. Hogaboam. 2002. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. FASEB J. 16:1313-1315.
54. Snijdewint, F. G., P. Kalinski, E. A. Wierenga, J. D. Bos, and M. L. Kapsenberg. 1993. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321-5329.
55. Southam, D. S., M. Dolovich, P. M. O'Byrne, and M. D. Inman. 2002. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L833-L839.
56. Strachan, D. P. 1989. Hay fever, hygiene, and household size. BMJ 299: 1259-1260.
57. Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1994. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180:2365-2370.
58. Sudo, N., S. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739-1745.
59. Takabayashi, K., L. Libet, D. Chisholm, J. Zubeldia, and A. A. Horner. 2003. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice. J. Immunol. 170:3898-3905.
60. Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169:6482-6489.
61. Ueta, E., K. Yoneda, T. Yamamoto, and T. Osaki. 1992. Upregulatory effects of cefpimizole natrium on human leukocytes. Int. J. Immunopharmacol. 14:877-885.
62. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
63. Villa, M. L., S. Armelloni, E. Ferrario, F. Ottaviani, and M. Clerici. 1991. Interference of cephalosporins with immune response: effects of cefonicid on human T-helper cells. Int. J. Immunopharmacol. 13:1099-1107.
64. Whitacre, C. C., I. E. Gienapp, A. Meyer, K. L. Cox, and N. Javed. 1996. Oral tolerance in experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 778:217-227.
65. Wickens, K., N. Pearce, J. Crane, and R. Beasley. 1999. Antibiotic use in early childhood and the development of asthma. Clin. Exp. Allergy 29:766-771.
66. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
67. Wills-Karp, M., J. Santeliz, and C. L. Karp. 2001. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69-75.
68. Wjst, M., B. Hoelscher, C. Frye, H. E. Wichmann, S. Dold, and J. Heinrich. 2001. Early antibiotic treatment and later asthma. Eur. J. Med. Res. 6:263-271.
69. Wu, X. M., M. Nakashima, and T. Watanabe. 1998. Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance. Eur. J. Immunol. 28:134-142.
70. Yamanaka, T., L. Helgeland, I. N. Farstad, H. Fukushima, T. Midtvedt, and P. Brandtzaeg. 2003. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J. Immunol. 170:816-822.
71. Zhang, X., L. Izikson, L. Liu, and H. L. Weiner. 2001. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 167:4245-4253.